So, what happened with this? The two contract m
Post# of 36537
The two contract manufacturers will produce and
package Excellagen in two dose formulations for the initial product launch in the first quarter of 2019,
with a third dosage option for large wounds to follow shortly thereafter.
Did they sell out those they produced in the 1st quarter and what happened with the third option?
Read More: https://investorshangout.com/post/view?id=563...z69iYaInVx